Make no mistake, either Agentforce is Salesforce's future or its future looks pretty bleak. For now, most CRM investors are ecstatic about the product's possibilities. Ditto for its just-announced ...
Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...
Curt Cignetti and Dan Lanning, head coaches of the Hoosiers and Ducks, respectively, spoke with the media on Thursday ahead ...
This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
The encryption protecting billions of dollars, which experts once called unbreakable, no longer works. Hackers don’t need passwords. They don’t brute-force keys. They simply walk through digital ...
Asheville Watchdog on MSNOpinion
Missing middle plan shows the path to more affordable housing. Why isn’t Asheville following it?
Though “missing middle” housing is often accessible to middle-income families, the term refers not to price range but density ...
Over the past year, enterprise adoption of generative AI has shifted from small experiments with large language models to ...
1don MSNOpinion
Trump’s risky fixation with other countries’ oil
Venezuela operation reflects a long-held desire to leverage military might into control over energy—though falling prices are ...
Last year may have been one of culinary opulence, but most of our favorite openings were downright approachable.
Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical's first-in-class SCD therapy for the adult AKI indication - a potent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results